Azenta (AZTA) Expected to Post Earnings on Tuesday

Azenta (NASDAQ:AZTA) is expected to be releasing its Q4 2026 results after the market closes on Tuesday, November 10th. Analysts expect Azenta to announce earnings of $0.1110 per share and revenue of $160.21 million for the quarter. Investors can check the company’s upcoming Q4 2026 earnings summary page for the latest details on the call scheduled for Wednesday, November 11, 2026 at 8:30 AM ET.

Azenta Price Performance

Azenta stock opened at $39.16 on Monday. The firm has a 50 day moving average price of $35.32 and a 200-day moving average price of $28.47. Azenta has a twelve month low of $15.93 and a twelve month high of $46.41. The company has a market capitalization of $1.72 billion, a P/E ratio of -14.19 and a beta of 1.47.

Analyst Ratings Changes

Several equities analysts recently commented on AZTA shares. Weiss Ratings upgraded Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 26th. Wall Street Zen downgraded Azenta from a “buy” rating to a “hold” rating in a research report on Sunday, October 18th. Finally, Needham & Company LLC restated a “buy” rating and issued a $37.00 target price on shares of Azenta in a research note on Monday, September 14th. Four analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $41.20.

Azenta Company Profile

Azenta, Inc is a life sciences company that provides products and services for the management, storage, and analysis of biological and chemical samples. Its offerings support pharmaceutical, biotechnology, academic, and clinical research organizations throughout the sample lifecycle, from collection and processing to long-term storage and retrieval.

The company’s portfolio includes automated and ultra-low-temperature sample storage systems, laboratory automation equipment, consumables, and software for sample tracking and management.